Peter Mack

Peter Mack, PhD joined MindMed from AstraZeneca, most recently as Director of Manufacturing, where he led functional and matrix teams in Pharmaceutical Technology and Development resulting in successful Phase 3 development and global marketing application approval of two commercial products – Bevespi Aerosphere ® and Breztri Aerosphere ®. Peter previously worked at Pearl Therapeutics (acquired by AstraZeneca in 2013) and Liquidia Technologies, where he helped pioneer the development of novel inhaled therapies for highly prevalent respiratory diseases. Peter holds a dual PhD in Medical Engineering and Medical Physics from Harvard Medical School and Massachusetts Institute of Technology (MIT), where he was a National Institute of Health (NIH) Biomechanics Training Grant Recipient. Peter also holds a Masters of Science in Mechanical Engineering from MIT and a Bachelors of Science in Mechanical Engineering from the University of Notre Dame. During his time in academia and the pharmaceutical industry, Peter has contributed to numerous peer reviewed articles and patents.